Abstract
Formaldehyde (FA) is a product of an endogenous production that is formed through demethylase and oxidase enzymes, which regulate epigenetics and metabolism. However, the presence of abnormally high levels of FA are often associated with a variety of disease pathologies, including chronic liver, heart and neurodegenerative diseases, in addition to diabetes and various cancers. Hence, a more efficient tool for monitoring FA in living systems is required to better investigate the biological roles of FA in physiology and pathology. Herein, describe a new aggregation-induced emission based fluorescent probe (MPIPA) to detect formaldehyde (FA) with high selectivity and an ultra-low detection limit (123 nM). Importantly, the new probe permits the successfully detection of exogenous and endogenous FA in living cells and clinical cancer tissues for the first time, which has important implications.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.